Company Name
Achieve Life Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US0044685008
CIK:
0000949858
CUSIP:
835692104
Currency:
USD
Full Time Employees:
25
Phone:
604 210 2217
Website:
https://www.achievelifesciences.com
Fiscal Year End:
December
IPO Date:
Oct 13, 1995
Description:
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Address:
22722 29th Dr. SE, Bothell, WA, United States, 98021